A. Compston

1.4k total citations
11 papers, 272 citations indexed

About

A. Compston is a scholar working on Pathology and Forensic Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, A. Compston has authored 11 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 2 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in A. Compston's work include Multiple Sclerosis Research Studies (4 papers), Viral gastroenteritis research and epidemiology (1 paper) and Viral Infections and Immunology Research (1 paper). A. Compston is often cited by papers focused on Multiple Sclerosis Research Studies (4 papers), Viral gastroenteritis research and epidemiology (1 paper) and Viral Infections and Immunology Research (1 paper). A. Compston collaborates with scholars based in United Kingdom. A. Compston's co-authors include Neil Scolding, Martin Stangel, Douglas L. Arnold, Hans‐Peter Hartung, Eva Havrdová, Krzysztof Selmaj, M. Stojanovic, Alasdair Coles, David Margolin and C Confavreux and has published in prestigious journals such as Neurology, Journal of Neurology Neurosurgery & Psychiatry and Journal of Neuroimmunology.

In The Last Decade

A. Compston

10 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Compston United Kingdom	6	142	126	70	52	44	11	272
Takeshi Kezuka Japan	14	124 0.9×	153 1.2×	124 1.8×	38 0.7×	65 1.5×	20	495
Shunsuke Yoshimura Japan	8	120 0.8×	69 0.5×	56 0.8×	31 0.6×	58 1.3×	37	252
Erkingül Shugaiv Türkiye	12	129 0.9×	110 0.9×	91 1.3×	26 0.5×	33 0.8×	18	298
Elisabet Matas Spain	11	128 0.9×	306 2.4×	93 1.3×	23 0.4×	64 1.5×	23	419
В. Д. Назаров Russia	7	61 0.4×	117 0.9×	64 0.9×	19 0.4×	52 1.2×	45	247
J. Masjuán Spain	6	245 1.7×	283 2.2×	103 1.5×	22 0.4×	37 0.8×	8	376
Armando Flor United States	6	91 0.6×	183 1.5×	36 0.5×	24 0.5×	48 1.1×	8	315
Sebahattin Saip Türkiye	6	119 0.8×	199 1.6×	78 1.1×	14 0.3×	46 1.0×	7	316
Huasheng Yang China	10	57 0.4×	118 0.9×	40 0.6×	22 0.4×	54 1.2×	24	281
Nathan R. McGee United States	11	194 1.4×	31 0.2×	64 0.9×	24 0.5×	51 1.2×	18	297

Countries citing papers authored by A. Compston

Since Specialization

Citations

This map shows the geographic impact of A. Compston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Compston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Compston more than expected).

Fields of papers citing papers by A. Compston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Compston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Compston. The network helps show where A. Compston may publish in the future.

Co-authorship network of co-authors of A. Compston

This figure shows the co-authorship network connecting the top 25 collaborators of A. Compston. A scholar is included among the top collaborators of A. Compston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Compston. A. Compston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Arnold, Douglas L., Vesna Brinar, J. A. Cohen, et al.. (2012). Effect of Alemtuzumab vs. Rebif(R) on Brain MRI Measurements: Results of CARE-MS I, a Phase 3 Study (S11.006). Neurology. 78(Meeting Abstracts 1). S11.006–S11.006. 5 indexed citations

2.

Coles, Alasdair, Vesna Brinar, Douglas L. Arnold, et al.. (2012). Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif(R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients (S01.006). Neurology. 78(Meeting Abstracts 1). S01.006–S01.006. 5 indexed citations

3.

Selmaj, Krzysztof, Douglas L. Arnold, Vesna Brinar, et al.. (2012). Incidence of Autoimmunity in a Phase 3 Trial: Comparison of Alemtuzumab and Rebif(R) in Multiple Sclerosis I (CARE-MS I) (S41.006). Neurology. 78(Meeting Abstracts 1). S41.006–S41.006. 3 indexed citations

4.

Compston, A.. (2010). What got me into neurology (and did it work out?). Practical Neurology. 10(2). 107–108. 1 indexed citations

5.

Compston, A.. (2000). The Genetics of Multiple Sclerosis. Clinical Chemistry and Laboratory Medicine (CCLM). 38(2). 133–135. 14 indexed citations

6.

Stangel, Martin, A. Compston, & Neil Scolding. (1999). Polyclonal immunoglobulins for intravenous use do not influence the behaviour of cultured oligodendrocytes. Journal of Neuroimmunology. 96(2). 228–233. 23 indexed citations

7.

Compston, A.. (1999). The pathological anatomy of the lesion in multiple sclerosis. Brain Research Bulletin. 50(5-6). 463–464. 1 indexed citations

8.

Compston, A.. (1998). Future Options for Therapies to Limit Damage and Enhance Recovery. Seminars in Neurology. 18(3). 405–414. 6 indexed citations

9.

Compston, A.. (1997). Genetic epidemiology of multiple sclerosis.. Journal of Neurology Neurosurgery & Psychiatry. 62(6). 553–561. 86 indexed citations

10.

Compston, A.. (1994). The Neurofibromatoses. A pathogenetic and clinical overview. Journal of Neurology Neurosurgery & Psychiatry. 57(10). 1301–1301. 125 indexed citations

11.

Compston, A.. (1986). The modern management of multiple sclerosis.. PubMed. 36(3). 200–1, 204. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact